TY - JOUR
T1 - Survival in immunocompromised patients ultimately requiring invasive mechanical ventilation
T2 - A pooled individual patient data analysis
AU - Dumas, Guillaume
AU - Lemiale, Virginie
AU - Rathi, Nisha
AU - Cortegiani, Andrea
AU - Pené, Frédéric
AU - Bonny, Vincent
AU - Salluh, Jorge
AU - Albaiceta, Guillermo M.
AU - Soares, Marcio
AU - Soubani, Ayman O.
AU - Canet, Emmanuel
AU - Hanane, Tarik
AU - Kouatchet, Achille
AU - Mokart, Djamel
AU - Lebiedz, Pia
AU - Türkoğlu, Melda
AU - Coudroy, Rémi
AU - Jeon, Kyeongman
AU - Demoule, Alexandre
AU - Mehta, Sangeeta
AU - Caruso, Pedro
AU - Frat, Jean Pierre
AU - Yang, Kuang Yao
AU - Roca, Oriol
AU - Laffey, John
AU - Timsit, Jean François
AU - Azoulay, Elie
AU - Darmon, Michael
N1 - Publisher Copyright:
Copyright © 2021 by the American Thoracic Society
PY - 2021/7/15
Y1 - 2021/7/15
N2 - Rationale: Acute respiratory failure (ARF) is associated with high mortality in immunocompromised patients, particularly when invasive mechanical ventilation is needed. Therefore, noninvasive oxygenation/ventilation strategies have been developed to avoid intubation, with uncertain impact on mortality, especially when intubation is delayed. Objectives: We sought to report trends of survival over time in immunocompromised patients receiving invasive mechanical ventilation. The impact of delayed intubation after failure of noninvasive strategies was also assessed. Methods: Systematic review and meta-analysis using individual patient data of studies that focused on immunocompromised adult patients with ARF requiring invasive mechanical ventilation. Studies published in English were identified through PubMed, Web of Science, and Cochrane Central (2008–2018). Individual patient data were requested from corresponding authors for all identified studies. We used mixed-effect models to estimate the effect of delayed intubation on hospital mortality and described mortality rates over time. Measurements and Main Results: A total of 11,087 patients were included (24 studies, three controlled trials, and 21 cohorts), of whom 7,736 (74%) were intubated within 24 hours of ICU admission (early intubation). The crude mortality rate was 53.2%. Adjusted survivals improved over time (from 1995 to 2017, odds ratio [OR] for hospital mortality per year, 0.96 [0.95–0.97]). For each elapsed day between ICU admission and intubation, mortality was higher (OR, 1.38 [1.26–1.52]; P, 0.001). Early intubation was significantly associated with lower mortality (OR, 0.83 [0.72–0.96]), regardless of initial oxygenation strategy. These results persisted after propensity score analysis (matched OR associated with delayed intubation, 1.56 [1.44–1.70]). Conclusions: In immunocompromised intubated patients, survival has improved over time. Time between ICU admission and intubation is a strong predictor of mortality, suggesting a detrimental effect of late initial oxygenation failure.
AB - Rationale: Acute respiratory failure (ARF) is associated with high mortality in immunocompromised patients, particularly when invasive mechanical ventilation is needed. Therefore, noninvasive oxygenation/ventilation strategies have been developed to avoid intubation, with uncertain impact on mortality, especially when intubation is delayed. Objectives: We sought to report trends of survival over time in immunocompromised patients receiving invasive mechanical ventilation. The impact of delayed intubation after failure of noninvasive strategies was also assessed. Methods: Systematic review and meta-analysis using individual patient data of studies that focused on immunocompromised adult patients with ARF requiring invasive mechanical ventilation. Studies published in English were identified through PubMed, Web of Science, and Cochrane Central (2008–2018). Individual patient data were requested from corresponding authors for all identified studies. We used mixed-effect models to estimate the effect of delayed intubation on hospital mortality and described mortality rates over time. Measurements and Main Results: A total of 11,087 patients were included (24 studies, three controlled trials, and 21 cohorts), of whom 7,736 (74%) were intubated within 24 hours of ICU admission (early intubation). The crude mortality rate was 53.2%. Adjusted survivals improved over time (from 1995 to 2017, odds ratio [OR] for hospital mortality per year, 0.96 [0.95–0.97]). For each elapsed day between ICU admission and intubation, mortality was higher (OR, 1.38 [1.26–1.52]; P, 0.001). Early intubation was significantly associated with lower mortality (OR, 0.83 [0.72–0.96]), regardless of initial oxygenation strategy. These results persisted after propensity score analysis (matched OR associated with delayed intubation, 1.56 [1.44–1.70]). Conclusions: In immunocompromised intubated patients, survival has improved over time. Time between ICU admission and intubation is a strong predictor of mortality, suggesting a detrimental effect of late initial oxygenation failure.
KW - Acute respiratory failure
KW - Immunocompromised
KW - Mechanical ventilation
UR - http://www.scopus.com/inward/record.url?scp=85110712817&partnerID=8YFLogxK
U2 - 10.1164/rccm.202009-3575OC
DO - 10.1164/rccm.202009-3575OC
M3 - Article
C2 - 33751920
AN - SCOPUS:85110712817
SN - 1073-449X
VL - 204
SP - 187
EP - 196
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 2
ER -